BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 19, 2018
View Archived Issues
Moleculin Biotech and MD Anderson discover new STAT3 inhibitor
Read More
Japanese approval for Actair for children with house dust mite-induced allergic rhinitis
Read More
Novoheart and Sumocor enter agreement to develop therapeutics for heart failure
Read More
RCGD-423 prevents articular cartilage degeneration and promotes repair in vivo
Read More
FDA grants orphan drug designation to ProMetic's IaIp for necrotizing enterocolitis
Read More
Novel Toll-like receptor 2 antagonists discovered at Neuropore Therapies
Read More
FDA issues complete response letter for Vitaros
Read More
Bayer patents new menin/MLL interaction inhibitors
Read More
IOCB Prague and Palecky University Olomouc describe new anticancer nucleosides
Read More
Dosing begins in phase Ib study of MYK-491
Read More
Bristol-Myers Squibb identifies novel Toll-like receptor 7/8/9 antagonists
Read More
New NMDA NR2 receptor modulators synthesized at Aptinyx
Read More
CSIC, Centre Hospitalier Universitaire Vaudois present novel compounds for pancreatic cancer
Read More
Gilead Sciences' Harvoni approved for new indication in Japan
Read More
Phase I results for VRC-5288 and VRC-5283 Zika virus DNA vaccine candidates
Read More
Avillion opens IND for phase II study of Merck KGaA's M-1095
Read More
Wilson Therapeutics initiates phase III trial of WTX-101 for Wilson's disease
Read More
FDA approves Imfinzi for unresectable stage III NSCLC
Read More
Palbociclib shows limited activity in metastatic urothelial cancer trial
Read More
Sumitomo Dainippon Pharma, Intercept amend obeticholic acid agreement
Read More
Shire presents clinical data on SHP-647 for the treatment of Crohn's disease
Read More
Rapid remission seen in Crohn's disease patients treated with upadacitinib
Read More
Fluarix Tetra approved in Europe for use from 6 months of age
Read More
FDA grants orphan drug designation to Hansa's IdeS for Guillain-Barre syndrome
Read More
Galderma signs joint research agreement on atopic dermatitis with Icahn and Northwestern University
Read More
Cincera Therapeutics launches with aim of treating diseases associated with obesity
Read More
Great Point Partners expresses opposition to BioCryst's proposed merger with Idera
Read More
TRDN user survey - We want your opinion
Read More